Clinical Trials on Drug Related Problem in New Zealand

Total 6475 results

New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal (AV411)

Opioid-Related Disorders

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Columbia University

Completed

Varenicline Treatment of Alcohol Dependence in Smokers

Smoking | Alcohol Drinking | Alcoholism | Alcohol Abuse

United States
Dartmouth-Hitchcock Medical Center

Completed

Computer-based Prescription Opioid Abuse Prevention for Adolescents

Opioid Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Facilitating Rapid Naltrexone Initiation

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine and Naltrexone Treatment for Opioid Dependence (NAMHS-1)

Opioid Dependence

United States
New York State Psychiatric Institute
Indivior Inc.

Completed

Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone

Heroin Dependence

United States
Hurd,Yasmin, Ph.D.

Completed

Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse

Opiate Addiction

United States
Biosense Webster, Inc.

Completed

THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS

Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Emergency Department Outcomes for Patients With Opioid Use Disorder

Opioid-use Disorder

United States
Yasmin Hurd

Recruiting

Cannabidiol for Opioid Addiction

Opioid Use Disorder

United States
Yasmin Hurd

Completed

Cannabidiol in the Treatment of Opioid Use Disorder

Opioid Use Disorder

United States
New York State Psychiatric Institute

Suspended

A Study of SPG Block for Opioid Withdrawal

Opioid Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Withdrawn

NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study (NT-814)

Opioid Use Disorder

United States
Montefiore Medical Center
National Institute on Drug Abuse (NIDA)

Terminated

BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3 (BUPFAST)

Opioid-related Disorders

United States
New York State Psychiatric Institute
Alkermes, Inc.

Terminated

Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals

Heroin Dependence

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Completed

Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry (XOR)

Opioid-Related Disorders | Heroin Dependence

United States
NYU Langone Health

Withdrawn

Needle-X: Usability Testing of a Smartphone Application

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Dronabinol Naltrexone Treatment for Opioid Dependence (Domino)

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Improved Strategies for Outpatient Opioid Detoxification

Opioid Dependence

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine and Naloxone Combination Study - 10

Opioid-Related Disorders | Heroin Dependence

United States
Ipsen

Completed

An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome (ELECT)

Carcinoid Syndrome

United States, Turkey, Brazil, India, Ukraine, South Africa, Czechia, Latvia, Poland, Russian Federation, Serbia
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (NAMHS)

Heroin Dependence | Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States
Yale University

Completed

Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET

Cocaine Dependence | Opiate Dependence

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Withdrawn

Assessing Optimal XR-Buprenorphine Initiation Points in Jail

Opioid Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Prescription Opioid Effects in Abusers Versus Non-Abusers

Substance-Related Disorders | Opioid-Related Disorders

United States
Novartis Pharmaceuticals

Completed

Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

Dyskinesias | Drug-induced

United States, France, Germany, Italy
Yale University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

FMRI of Stress and Addictive Disorders

Alcoholism | Opioid Dependence | Cocaine Dependence | Adolescents | Pathological Gamblers

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Nalrexone Facilitated Discontinuation of Buprenorphine

Stable Opioid Dependence

United States
NYU Langone Health
NYC Health + Hospitals

Completed

XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial

Opioid-Related Disorders | Heroin Dependence

United States
New York State Psychiatric Institute
Omeros Corporation

Completed

Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone

Opioid Abuse

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 1

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 4 - 4

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 1 - 1

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1

Opioid-Related Disorders

United States
Rutgers, The State University of New Jersey

Recruiting

Afferent Neurocardiac Signals, Cue Reactivity, and Cognitive Control

Binge Drinking

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder (ED-CONNECT)

Opioid-use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1

ADHD | Opioid-Related Disorders | Cocaine Dependence

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Aprepitant Effects in Intravenous Heroin Dependence

Opioid Dependence

United States
Hurd,Yasmin, Ph.D.

Completed

Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans

Opiate Addiction

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1

Heroin Dependence

United States
Rutgers, The State University of New Jersey
Pfizer

Completed

Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit

Tobacco Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1

Substance-Related Disorders | Opioid-Related Disorders | Cocaine-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Combining Behavioral Treatment With Agonist Maintenance - 1

Substance-Related Disorders | Opioid-Related Disorders | Cocaine-Related Disorders

United States
Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; New York State... and other collaborators

Completed

Pharmacokinetic Study of Vivitrol in Healthy Participants

Opioid-use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Suspended

Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder

Opioid-use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Subthreshold Opioid Use Disorder Prevention (STOP) Trial

Opioid-use Disorder

United States

Clinical Trials on Drug Related Problem in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations